Chester County News and Community Website
NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) announced the approval of equity awards under its 2021 Inducement Plan, effective August 14, 2024. The awards were granted as a …
Helius Medical Technologies Announces Equity Awards Under 2021 Inducement Plan Read More
NEWTOWN, PA — Traws Pharma, Inc. announced its second quarter 2024 financial results and highlighted key developments following its merger with Trawsfynydd Therapeutics. The merger, completed in April, included a …
Traws Pharma Reports Q2 Financials and Merger with Trawsfynydd Therapeutics Read More
LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) reported record revenue of $1.44 million for the second quarter of 2024, representing a 23.4% year-over-year increase. The company’s growth was driven significantly …
NEXGEL Announces Record Second Quarter Revenue and Strategic Developments Read More
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has made significant changes to its board of directors, effective August 13, 2024. The company has appointed Saundra Pelletier and Jed Latkin …
Windtree Therapeutics Announces New Board Appointments Read More
DOYLESTOWN, PA — Instinct Science has been named to the 2024 Inc. 5000 list of fastest-growing private companies in America. Achieving a notable 302% revenue growth from 2020 to 2023, …
Instinct Science Joins 2024 Inc. 5000 List with Rapid Growth Read More
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) recently reported its financial results for the second quarter ended June 30, 2024, alongside significant business developments. The company is …
Orchestra BioMed Holdings Reports Second Quarter 2024 Financial Results and Business Updates Read More LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) is set to release its financial results for the second quarter of 2024 after the market closes on August 14, 2024. Following the …
NEXGEL to Announce Second Quarter 2024 Financial Results Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq:HSDT) has announced its financial results for the quarter ended June 30, 2024, showcasing significant strides in both financial performance and business development. …
Helius Medical Technologies Reports Second Quarter 2024 Results and Major Milestones Read More LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) has announced definitive agreements this week for the issuance and sale of 444,000 shares of common stock and warrants to purchase an additional …
NEXGEL Announces Direct Offering and Strategic Acquisition to Fuel Growth Read More
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) has released its financial results for the second quarter ending June 30, 2024, alongside significant business updates that highlight the company’s strategic …
Aprea Therapeutics Reports Second Quarter 2024 Financial Results and Progress in Clinical Trials Read More